Pre-treatment biopsy

DIAGNOSTIC_TEST4 trials

Sponsors

Memorial Sloan Kettering Cancer Center, Institut Paoli-Calmettes, Center Eugene Marquis, University of Colorado, Denver

Conditions

Advanced or Metastatic Breast Cancer (BC)Colorectal Cancer Stage IVHER2-positive Breast CancerMetastatic Colorectal Cancer (CRC)Microsatellite Stable (MSS) Colorectal Cancer (CRC)Non Small Cell Lung Cancer

Phase 2

Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer

Active, not recruitingNCT06784947

University of Colorado, DenverColorectal Cancer Stage IV, Metastatic Colorectal Cancer (CRC), Microsatellite Stable (MSS) Colorectal Cancer (CRC)

Start: 2025-03-25End: 2028-05-31Updated: 2025-10-02

Unknown Phase

Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies

WithdrawnNCT03877250

Memorial Sloan Kettering Cancer CenterNon Small Cell Lung Cancer

Start: 2019-03-08End: 2020-08-26Updated: 2025-05-15

Trans-RosaLEE Study: a Biomarker-directed, Translational Study

Active, not recruitingNCT05529862

Institut Paoli-CalmettesAdvanced or Metastatic Breast Cancer (BC)

Start: 2023-06-20End: 2028-11-01Updated: 2026-01-22

Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer

RecruitingNCT06358625

Center Eugene MarquisHER2-positive Breast Cancer

Start: 2024-06-06End: 2031-06-06Target: 120Updated: 2025-08-01